For five years, CBI has guided the pharmaceutical industry in the U.S. through the intricacies of Sunshine regulations with our annual congress on Tracking State Laws and Aggregate Spend. Now, our...
For five years, CBI has guided the pharmaceutical industry in the U.S. through the intricacies of Sunshine regulations with our annual congress on Tracking State Laws and Aggregate Spend. Now, our attention turns to Europe with this inaugural event. The conference focuses exclusively on best practices for tracking and disclosing data regarding the company’s spend on HCPs, helping companies to implement systems that will ensure compliance going into the future.